Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...

Background: Racially and ethnically minoritized patients are underscreened for colorectal cancer, resulting in racial/ethnic disparities.

Multitarget stool DNA tests — which are becoming more popular in the United States — have shown increased sensitivity over fecal immunochemical tests (FITs) for early colorectal cancer (CRC) screening ...

Programs that support patients in the screening process or mail stool test kits to their homes are most effective at boosting colorectal cancer screening rates.

An at-home FIT test (Fecal Immunochemical Test) is one of the easiest ways to screen for colon cancer. This short explainer video shows who needs a FIT test, how it works, and how to ask your doctor ...

Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

A pragmatic cluster-randomized trial across 8 CHC sites (Boston and Los Angeles) enrolled 5127 adults aged 45–75 years overdue for screening, randomizing clinics to FIT versus FIT-DNA outreach.

SAN DIEGO -- An emphasis on fecal immunochemical testing (FIT) as a screening strategy for colorectal cancer allowed a Veterans Administration (VA) hospital to return to pre-COVID-19 pandemic ...

Consistent CRC screening — whether via FIT or combined methods — provides similar protections against CRC as early colonoscopy. Regular fecal immunochemical test (FIT) screening is associated with ...

Close to 50,000 Americans will die from colorectal cancer (CRC) in 2016, making it the second-leading cause of cancer-related death in this country (behind only lung cancer).1 What makes the statistic ...